Clinical Performance of HISTOACRYL® LAPFIX - CANNULA for Laparoscopic Inguinal Hernia Repair

Launched by AESCULAP AG · Mar 1, 2024

Keywords

ClinConnect Summary

This clinical trial is examining how well a specific medical product, called Histoacryl® Lapfix - Cannula, works in fixing mesh during laparoscopic surgery for inguinal hernias. An inguinal hernia happens when tissue pushes through a weak spot in the abdominal muscles, often requiring surgery to repair it. The study aims to find out how often hernias come back after using this product in surgeries performed between June 2018 and March 2021 at Hospital San Juan de Dios.

To participate in this study, patients need to be adults aged 18 or older who had laparoscopic inguinal hernia repair surgery at the specified hospital during the study timeframe. There are no exclusions based on health conditions, which means almost anyone who had this surgery can be part of the research. If eligible, patients will have their medical records reviewed to help gather information about their recovery and any recurrence of the hernia. This study is currently recruiting participants, and it aims to provide valuable insights into the effectiveness of this surgical technique.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients (≥18 years old)
• • treated between June 2018 and March 2021 at the Hospital San Juan de Dios for laparoscopic mesh fixation with Histoacryl Lapfix - Cannula after inguinal hernia repair surgery.
• Exclusion Criteria:
• • No exclusion criteria has been set.